Cubist Systematic Strategies’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-483,797
| Closed | -$9.6M | – | 1477 |
|
|
2025
Q1 | $9.6M | Buy |
483,797
+99,721
| +26% | +$1.98M | 0.06% | 237 |
|
|
2024
Q4 | $6.59M | Buy |
+384,076
| New | +$6.59M | 0.04% | 277 |
|
|
2024
Q3 | – | Sell |
-463,685
| Closed | -$5.18M | – | 1425 |
|
|
2024
Q2 | $5.18M | Sell |
463,685
-567,758
| -55% | -$6.35M | 0.04% | 325 |
|
|
2024
Q1 | $6.81M | Buy |
1,031,443
+800,512
| +347% | +$5.28M | 0.04% | 388 |
|
|
2023
Q4 | $1.04M | Sell |
230,931
-69,833
| -23% | -$316K | 0.01% | 1094 |
|
|
2023
Q3 | $1.08M | Sell |
300,764
-26,459
| -8% | -$94.7K | 0.01% | 1025 |
|
|
2023
Q2 | $1.21M | Buy |
327,223
+186,440
| +132% | +$688K | 0.01% | 1102 |
|
|
2023
Q1 | $466K | Buy |
140,783
+18,652
| +15% | +$61.7K | ﹤0.01% | 1837 |
|
|
2022
Q4 | $474K | Buy |
+122,131
| New | +$474K | ﹤0.01% | 2219 |
|
|
2022
Q2 | – | Sell |
-317,542
| Closed | -$581K | – | 3793 |
|
|
2022
Q1 | $581K | Buy |
317,542
+129,742
| +69% | +$237K | ﹤0.01% | 2417 |
|
|
2021
Q4 | $265K | Buy |
+187,800
| New | +$265K | ﹤0.01% | 2885 |
|
|
2021
Q3 | – | Sell |
-62,484
| Closed | -$100K | – | 2931 |
|
|
2021
Q2 | $100K | Buy |
62,484
+19,184
| +44% | +$30.7K | ﹤0.01% | 2714 |
|
|
2021
Q1 | $76K | Buy |
+43,300
| New | +$76K | ﹤0.01% | 2688 |
|
|
2020
Q2 | – | Sell |
-6,096
| Closed | -$18K | – | 2374 |
|
|
2020
Q1 | $18K | Buy |
+6,096
| New | +$18K | ﹤0.01% | 2067 |
|